HRP20070183A2 - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents
Use of androgens to reduce the likelihood of acquiring or to treat skin agingInfo
- Publication number
- HRP20070183A2 HRP20070183A2 HR20070183A HRP20070183A HRP20070183A2 HR P20070183 A2 HRP20070183 A2 HR P20070183A2 HR 20070183 A HR20070183 A HR 20070183A HR P20070183 A HRP20070183 A HR P20070183A HR P20070183 A2 HRP20070183 A2 HR P20070183A2
- Authority
- HR
- Croatia
- Prior art keywords
- likelihood
- acquiring
- loss
- androgens
- reduce
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title abstract 3
- 229940030486 androgens Drugs 0.000 title 1
- 230000009759 skin aging Effects 0.000 title 1
- 208000035484 Cellulite Diseases 0.000 abstract 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 206010040799 Skin atrophy Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004177 elastic tissue Anatomy 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 230000037373 wrinkle formation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62411204P | 2004-11-01 | 2004-11-01 | |
| PCT/CA2005/001652 WO2006047859A1 (en) | 2004-11-01 | 2005-10-31 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20070183A2 true HRP20070183A2 (en) | 2007-08-31 |
Family
ID=36318842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20070183A HRP20070183A2 (en) | 2004-11-01 | 2007-04-30 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060178352A1 (ru) |
| EP (1) | EP1807062A4 (ru) |
| JP (1) | JP2008517952A (ru) |
| KR (1) | KR20070073964A (ru) |
| CN (1) | CN101094676A (ru) |
| AP (1) | AP2007003982A0 (ru) |
| AU (1) | AU2005301035A1 (ru) |
| BR (1) | BRPI0517950A (ru) |
| CA (1) | CA2585666A1 (ru) |
| EA (1) | EA200700983A1 (ru) |
| GE (1) | GEP20094833B (ru) |
| HR (1) | HRP20070183A2 (ru) |
| IL (1) | IL182844A0 (ru) |
| MA (1) | MA29220B1 (ru) |
| MX (1) | MX2007005098A (ru) |
| NO (1) | NO20072642L (ru) |
| RS (1) | RS20070185A (ru) |
| TN (1) | TNSN07163A1 (ru) |
| WO (1) | WO2006047859A1 (ru) |
| ZA (1) | ZA200703531B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102357248A (zh) | 2004-10-20 | 2012-02-22 | 恩多研究公司 | 单独的性甾体前体或与选择性雌激素受体调节剂联合用于防治绝经后女性的阴道疾病和病症 |
| EP2012572B1 (en) | 2006-06-01 | 2018-07-04 | Panasonic Corporation | Brushless motor for washing machine and washing machine having the brushless motor mounted therein |
| US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
| EP3057667B1 (de) * | 2013-10-15 | 2020-03-04 | CHelac Holding GmbH | Steroid-carbonsäureester, zusammensetzungen, enthaltend steroid-carbonsäureester und verwendung dieser bei lokal topischer applikation für kosmetische oder dermatologische zwecke |
| JP6444956B2 (ja) * | 2015-09-30 | 2018-12-26 | 富士フイルム株式会社 | 経皮吸収用組成物 |
| CN114728013A (zh) * | 2019-09-23 | 2022-07-08 | 斯坦福大学托管董事会 | 延长妊娠以及月经或妊娠的并发症的治疗方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL88180C (ru) * | 1953-08-26 | |||
| ATE275957T1 (de) * | 1993-01-19 | 2004-10-15 | Endorech Inc | Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron |
| FR2729854A1 (fr) * | 1995-01-26 | 1996-08-02 | Oreal | Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique |
| US5736537A (en) * | 1995-09-12 | 1998-04-07 | Estee Lauder, Inc. | Dehydroep:androsterone sailcylate useful against skin atrophy |
| US5709878A (en) * | 1996-08-02 | 1998-01-20 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| US5869090A (en) * | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| NZ536787A (en) * | 1998-06-11 | 2006-03-31 | Endorech Inc | Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol |
| US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
| FR2803750B1 (fr) * | 2000-01-17 | 2004-04-02 | Assist Publ Hopitaux De Paris | Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant |
| US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
| US20030027804A1 (en) * | 2001-06-27 | 2003-02-06 | Van Der Hoop Roland Gerritsen | Therapeutic combinations for the treatment of hormone deficiencies |
| JP2004002321A (ja) * | 2002-03-11 | 2004-01-08 | Takeda Chem Ind Ltd | 性ホルモン依存性疾患治療剤 |
| IL157535A0 (en) * | 2003-08-21 | 2004-03-28 | Topimed Ltd | Preparations for the prevention of skin atrophy |
-
2005
- 2005-10-31 KR KR1020077012537A patent/KR20070073964A/ko not_active Application Discontinuation
- 2005-10-31 GE GEAP200510104A patent/GEP20094833B/en unknown
- 2005-10-31 AU AU2005301035A patent/AU2005301035A1/en not_active Abandoned
- 2005-10-31 JP JP2007538225A patent/JP2008517952A/ja active Pending
- 2005-10-31 RS RSP-2007/0185A patent/RS20070185A/sr unknown
- 2005-10-31 CA CA002585666A patent/CA2585666A1/en not_active Abandoned
- 2005-10-31 CN CNA2005800456687A patent/CN101094676A/zh active Pending
- 2005-10-31 MX MX2007005098A patent/MX2007005098A/es not_active Application Discontinuation
- 2005-10-31 EP EP05799216A patent/EP1807062A4/en not_active Withdrawn
- 2005-10-31 EA EA200700983A patent/EA200700983A1/ru unknown
- 2005-10-31 BR BRPI0517950-5A patent/BRPI0517950A/pt not_active IP Right Cessation
- 2005-10-31 WO PCT/CA2005/001652 patent/WO2006047859A1/en active Application Filing
- 2005-10-31 AP AP2007003982A patent/AP2007003982A0/xx unknown
- 2005-11-01 US US11/264,704 patent/US20060178352A1/en not_active Abandoned
-
2007
- 2007-04-27 TN TNP2007000163A patent/TNSN07163A1/fr unknown
- 2007-04-29 IL IL182844A patent/IL182844A0/en unknown
- 2007-04-30 HR HR20070183A patent/HRP20070183A2/xx not_active Application Discontinuation
- 2007-04-30 ZA ZA200703531A patent/ZA200703531B/xx unknown
- 2007-05-23 NO NO20072642A patent/NO20072642L/no not_active Application Discontinuation
- 2007-05-30 MA MA29957A patent/MA29220B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060178352A1 (en) | 2006-08-10 |
| BRPI0517950A (pt) | 2008-10-21 |
| EA200700983A1 (ru) | 2008-04-28 |
| EP1807062A1 (en) | 2007-07-18 |
| CA2585666A1 (en) | 2006-05-11 |
| JP2008517952A (ja) | 2008-05-29 |
| AP2007003982A0 (en) | 2007-06-30 |
| KR20070073964A (ko) | 2007-07-10 |
| CN101094676A (zh) | 2007-12-26 |
| MA29220B1 (fr) | 2008-02-01 |
| WO2006047859A1 (en) | 2006-05-11 |
| TNSN07163A1 (en) | 2008-11-21 |
| RS20070185A (en) | 2008-09-29 |
| NO20072642L (no) | 2007-07-30 |
| GEP20094833B (en) | 2009-11-25 |
| ZA200703531B (en) | 2008-07-30 |
| EP1807062A4 (en) | 2009-06-03 |
| IL182844A0 (en) | 2007-09-20 |
| MX2007005098A (es) | 2008-01-16 |
| AU2005301035A1 (en) | 2006-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20070183A2 (en) | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | |
| WO2019004673A3 (ko) | 유산균 유래의 세포밖 베지클을 포함하는 항노화용 조성물 | |
| DE502005010615D1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| TW200509956A (en) | Compositions and methods for treatment of rosacea | |
| ATE269113T1 (de) | Sprühfähige wundversorgungszusammensetzung | |
| WO2006073786A3 (en) | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy | |
| WO2005105107A3 (en) | Hormone treatment of multiple sclerosis | |
| BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
| AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
| ATE500817T1 (de) | Schäumbare zusammensetzung, die im wesentlichen frei von pharmazeutisch aktiven inhaltsstoffen ist, zur behandlung der menschlichen haut | |
| ATE500855T1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| EA200870393A1 (ru) | Новые композиции для нарушений волос и способ получения композиций | |
| MX2011010781A (es) | Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla. | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| ATE333885T1 (de) | Verwendung von sulodexid zur behandlung von reizdarm | |
| WO2007087583A9 (en) | COMPOSITIONS AND METHODS FOR TREATING SKIN SCARS AND WRINKLES | |
| ATE550015T1 (de) | Verfahren und zusammensetzung zur behandlung von rhinitis | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| MX2010009624A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. | |
| HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
| WO2007029188A3 (en) | Method of using fabric care compositions to achieve a synergistic odor benefit | |
| DE60330888D1 (de) | Verwendung von drospirenon zur behandlung von hypertension | |
| EA201591793A1 (ru) | Лактамные соединения в качестве селективных агонистов ep4-рецепторов для применения при лечении опосредованных ep4 заболеваний и состояний | |
| WO2010119366A3 (en) | A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same | |
| WO2009106715A3 (fr) | Peptide derive d'une proteine de la famille des aquaporines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20091014 Year of fee payment: 5 |
|
| OBST | Application withdrawn |